Identifying sites bound by Epstein-Barr Virus nuclear antigen 1 (EBNA1) in the human genome: Defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes

Journal of Virology

Volumn 83, Issue 7, 2009, Pages 2930-2940

  Dresang, Lindsay R ^a   Vereide, David T ^a   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; DNA; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; VIRUS DNA;

ARTICLE; BINDING SITE; CELL STRAIN RAJI; CERCOPITHECINE HERPESVIRUS 15; CHROMATIN IMMUNOPRECIPITATION; DNA BINDING; EPSTEIN BARR VIRUS; GENE LOCUS; HUMAN GENOME; HUMAN HERPESVIRUS 8; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; ANIMAL; CELL LINE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN MICROARRAY; VIRUS REPLICATION;

CERCOPITHECINE HERPESVIRUS 12; CERCOPITHECINE HERPESVIRUS 15; HUMAN HERPESVIRUS 4;

ANIMALS; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA; DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENOME, HUMAN; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; VIRUS REPLICATION;

EID: 63149089891     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01974-08     Document Type: Article

References (58)

1. Aiyar, A., C. Tyree, and B. Sugden. 1998. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17:6394-6403.
2. Altmann, M., D. Pich, R. Ruiss. J. Wang, B. Sugden, and W. Hammer-Schmidt. 2006. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc. Natl. Acad. Sci. USA 103:14188-14193.
3. Ambinder, R. F., W. A. Shah, D. R. Rawlins, G. S. Hayward, and S. D. Hayward. 1990. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 64:2369-2379.
4. Andersson-Anvret, M, N. Forsby, G. Klein, and W. Henle. 1977. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int. J. Cancer 20:486-494.
5. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Séguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
6. Bailey, T. L., and C. Elkan. 1994. Fitting a mixture model by expectation maximization to discover motifs in biopolymers, p. 28-36. In Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology. AAAI Press, Menlo Park, CA.
7. Bailey, T. L., and M. Gribskov. 1998. Combining evidence using p-values: application to sequence homology searches. Bioinformatics 14:48-54.
8. Bailey, T. L., N. Williams, C. Misleh, and W. W. Li. 2006. MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res. 34:W369-W373.
9. Bashaw, J. M., and J. L. Yates. 2001. Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J. Virol. 75:10603-10611.
10. Bochkarev, A., J. A. Barwell, R. A. Pfuetzner, E. Bochkareva, L. Frappier, and A. M. Edwards. 1996. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84:791-800.
11. Bochkarev, A., J. A. Barwell, R. A. Pfuetzner, W. Furey, Jr., A. M. Edwards, and L. Frappier. 1995. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1. Cell 83:39-46.
12. Crooks, G. E., G. Hon, J. M. Chandonia, and S. E. Brenner. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-1190.
13. Cruickshank, J., K. Shire, A. R. Davidson, A. M. Edwards, and L. Frappier. 2000. Two domains of the Epstein-Barr virus origin DNA-binding protein, EBNA1, orchestrate sequence-specific DNA-binding. J. Biol. Chem. 275: 22273-22277.
14. Flavell, J. R., K. R. N. Baumforth, V. H. J. Wood, G. L. Davies, W. Wei, G. M. Reynolds, S. Morgan, A. Boyce, G. L. Kelly, L. S. Young, and P. G. Murray. 2008. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus-encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood 111:292-301.
15. Frappier, L., and M. O'Donnell. 1991. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J. Biol. Chem. 266:7819-7826.
16. Fujita, T., M. Ikeda, S. Kusano, M. Yamazaki, S. Ito, M. Obayashi, and K. Yanagi. 2001. Amino acid substitution analyses of the DNA contact region, two amphipathic α-helices and a recognition-helix-like helix outside the dimeric β-barrel of Epstein-Barr virus nuclear antigen 1. Intervirology 44: 271-282.
17. Gahn, T. A., and B. Sugden. 1995. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
18. Glaser, S. L., R. J. Lin, S. L. Stewart, R. F. Ambinder, R. F. Jarrett, P. Brousset, G. Pallesen, M. L. Gulley, G. Khan, J. O'Grady, M. Hummel, M. V. Preciado, H. Knecht, J. K. Chan, and A. Claviez. 1997. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int. J. Cancer 70:375-382.
19. Hammerschmidt, W., and B. Sugden. 2004. Epstein-Barr virus sustains Bur-kitt's lymphomas and Hodgkin's disease. Trends Mol. Med. 10:331-336.
20. Hammerschmidt, W., and B. Sugden. 2006. Epstein-Barr virus, p. 687-705. In M. DePamphilis (ed.), DNA replication and human disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Hebner, C., J. Lasanen, S. Battle, and A. Aiyar. 2003. The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance. Virology 311:263-274.
22. Hegde, R. S., S. R. Grossman, L. A. Laimins, and P. B. Sigler. 1992. Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359:505-512.
23. Horner, D., M. Lewis, and P. J. Farrell. 1995. Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers. Intervirology 38:195-205.
24. Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77:4251-4255.
25. Kennedy, G., J. Komano, and B. Sugden. 2003. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. USA 100: 14269-14274.
26. Kennedy, G., and B. Sugden. 2003. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 23:6901-6908.
27. *: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J. Virol. 72:4657-4666.
28. Knutson, J. C., and D. Yee. 1987. Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal. Biochem. 164:44-52.
29. Langle-Rouault, F., V. Patzel, A. Benavente, M. Taillez, N. Silvestre, A. Bompard, G. Sczakiel, E. Jacobs, and K. Rittner. 1998. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J. Virol. 72:6181-6185.
30. Lindner, S. E., K. Zeller, A. Schepers, and B. Sugden. 2008. The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency. J. Virol. 82:5693-5702.
31. Loeb, D. D., N. S. Sung, R. L. Pesano, C. J. Sexton, C. Hutchison in, and J. S. Pagano. 1990. Plasmid origin of replication of herpesviras papio: DNA sequence and enhancer function. J. Virol. 64:2876-2883.
32. Lupton, S., and A. J. Levine. 1985. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5:2533-2542.
33. Mack, A. A., and B. Sugden. 2008. EBV is necessary for proliferation of dually infected primary effusion lymphoma cells. Cancer Res. 68:6963-6968.
34. Mackey, D., and B. Sugden. 1999. The linking regions of EBNA1 are essential for its support of replication and transcription. Mol. Cell. Biol. 19:3349-3359.
35. Menezes, J., W. Leibold, G. Klein, and G. Clements. 1975. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22:276-284.
36. Middleton, T., and B. Sugden. 1992. EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J. Virol. 66:489-495.
37. Nilsson, T., H. Zetterberg, Y. C. Wang, and L. Rymo. 2001. Promoter-proximal regulatory elements involved in oriP-EBNAl-independent and -dependent activation of the Epstein-Barr virus C promoter in B-Iymphoid cell lines. J. Virol. 75:5796-5811.
38. Ostrin, E. J., Y. Li, K. Hoffman, J. Liu, K. Wang, L. Zhang, G. Mardon, and R. Chen. 2006. Genome-wide identification of direct targets of the Drosoph-ila retinal determination protein Eyeless. Genome Res. 16:466-476.
39. Pesano, R. L., and J. S. Pagano. 1986. Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function. J. Virol. 60:1159-1162.
40. Puglielli, M. T., M. Woisetschlaeger, and S. H. Speck. 1996. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J. Virol. 70:5758-5768.
41. Pulvertaft, J. V. 1965. A study of malignant tumours in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:261-273.
42. Reisman, D., and B. Sugden. 1986. trans Activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
43. Rivailler, P., H. Jiang, Y. Cho, C. Quink, and F. Wang. 2002. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J. Virol. 76:421-426.
44. Ruf, I. K., A. Moghaddam, F. Wang, and J. Sample. 1999. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptovirases of old world primates. J. Virol. 73:1980-1989.
45. Sample, J., E. B. Henson, and C. Sample. 1992. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J. Virol. 66:4654-4661.
46. Schneider, T. D., and R. M. Stephens. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18:6097-6100.
47. Sugden, B., and N. Warren. 1989. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63:2644-2649.
48. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:4876-4882.
49. Thompson, M. P., and R. Kurzrock. 2004. Epstein-Barr virus and cancer. Clin. Cancer Res. 10:803-821.
50. Wang, C., and B. Sugden. 2008. Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells. Proc. Natl. Acad. Sci. USA 105:9639-9644.
51. Wang, J., S. E. Lindner, E. R. Leight, and B. Sugden. 2006. Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Mol. Cell. Biol. 26:1124-1134.
52. Wood, V. H. J., J. D. O'Neil, W. Wei, S. E. Stewart, C. W. Dawson, and L. S. Young. 2007. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways. Oncogene 26:4135-4147.
53. Wu, M. S., C. T. Shun, C. C. Wu, T. Y. Hsu, M. T. Lin, M. C. Chang, H. P. Wang, and J. T. Lin. 2000. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 118: 1031-1038.
54. Wysokenski, D. A., and J. L. Yates. 1989. Multiple EBNAl-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63:2657-2666.
55. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of re-combinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
56. Yates, J. L., S. M. Camiolo, S. Ali, and A. Ying. 1996. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222:1-13.
57. Yoshioka, M., M. M. Crum, and J. T. Sample. 2008. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing. J. Virol. 82:1679-1687.
58. Zeng, Y, L. G. Zhang, Y. C. Wu, Y. S. Huang, N. Q. Huang, J. Y. Li, Y. B. Wang, M. K. Jiang, Z. Fang, and N. N. Meng. 1985. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int. J. Cancer 36:545-547.